Related Experiment Video
Updated: Jun 11, 2026
07:12
Spatio-Temporal In Vivo Imaging of Ocular Drug Delivery Systems using Fiberoptic Confocal Laser Microendoscopy
Published on: September 27, 2021
Monitoring the eye lens: which dose quantity is adequate?
1Physikalisch-Technische Bundesanstalt, Bundesallee 100, D-38116 Braunschweig, Germany. rolf.behrens@ptb.de
Physics in Medicine and Biology
|July 6, 2010
Summary
New research suggests current eye lens dose monitoring may need updating. Using H(p)(3) may be necessary for beta radiation fields to ensure accurate eye lens dose assessment and protection.
Area of Science:
- Radiation Dosimetry
- Ocular Health
- Radiological Protection
Background:
- Epidemiological studies indicate a low or non-existent threshold for radiation-induced cataracts.
- Current occupational dose limits for the eye lens may require revision.
- The adequacy of current personal dose equivalent quantities for eye lens monitoring is under scrutiny.
Purpose of the Study:
- To evaluate the appropriateness of different personal dose equivalent quantities for monitoring eye lens dose.
- To determine dose conversion coefficients for eye lens dose in realistic radiation fields.
- To compare these coefficients with operational quantities for improved radiological protection.
Main Methods:
- Calculated dose conversion coefficients for equivalent dose to the eye lens.
- Utilized realistic photon and beta radiation fields for simulations.
- Compared calculated coefficients with operational quantities H(p)(0.07) and H(p)(3).
Main Results:
- For photon-dominated fields (e.g., X-rays), H(p)(0.07) is appropriate.
- For beta-radiation-dominated or mixed fields, H(p)(3) is recommended.
- Using H(p)(0.07) in certain beta fields can lead to significant overestimation of eye lens dose.
Conclusions:
- The choice of dose monitoring quantity depends on the radiation field composition.
- H(p)(3) offers better accuracy in mixed or beta-radiation fields.
- Optimized protection measures and potentially revised dose limits are necessary for eye lens safety.
Related Concept Videos
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
01:21Dose Size and Dosing Frequency: Determination Methods
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...